WHO endorses GLP-1 drugs for obesity treatment

The World Health Organization (WHO) has recommended the use of GLP-1 drugs for obesity management in adults, marking a significant change in its approach to obesity treatment. These medications, which suppress appetite by mimicking a fullness hormone, should be used alongside lifestyle counseling. While the WHO acknowledges that medication alone can’t address the obesity crisis, it emphasizes the need for more long-term data on safety and efficacy. The recommendation is conditional, urging lower prices for broader access to these treatments.

Want More Context? 🔎